Targeted pneumococcal conjugate vaccination strategies for high-risk children

Area of Science:

• Pediatrics
• Infectious Diseases
• Immunology

Background:

• * *Streptococcus pneumoniae* is a leading cause of pneumonia mortality in children under five, particularly in low- and middle-income countries (LMICs).
• * Malnutrition, measles, and malaria impair immune function, significantly increasing the risk of severe pneumonia and death in children.
• * Current research and specific recommendations for pneumococcal conjugate vaccines (PCVs) in these high-risk populations are limited.

Purpose of the Study:

• * To summarize the disease burden and immune vulnerability in children with malnutrition, measles, or malaria.
• * To highlight research priorities for developing targeted PCV strategies in LMICs.
• * To inform evidence-based PCV recommendations for high-risk pediatric populations.

Main Methods:

• * Mini-review of existing literature on *Streptococcus pneumoniae* disease burden.
• * Analysis of immune dysfunction associated with malnutrition, measles, and malaria in children.
• * Identification of research gaps and priorities for PCV implementation.

Main Results:

• * Children with malnutrition, measles, or malaria face a disproportionately high risk of severe pneumococcal disease.
• * Immune dysfunction in these groups exacerbates pneumonia severity and mortality.
• * There is a critical need for research to guide targeted PCV strategies in LMICs.

Conclusions:

• * Targeted PCV strategies, aligned with periods of peak vulnerability, are crucial for reducing childhood pneumonia mortality in LMICs.
• * Further research is essential to optimize PCV use in high-risk pediatric populations affected by malnutrition, measles, and malaria.
• * Addressing these specific vulnerabilities can significantly impact global child survival rates.